- Home
- IHRT vs RAPT Comparison
IHRT vs RAPT Comparison
Compare IHRT & RAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IHRT
- RAPT
- Stock Information
- Founded
- IHRT 1974
- RAPT 2015
- Country
- IHRT United States
- RAPT United States
- Employees
- IHRT N/A
- RAPT N/A
- Industry
- IHRT Broadcasting
- RAPT Biotechnology: Pharmaceutical Preparations
- Sector
- IHRT Consumer Discretionary
- RAPT Health Care
- Exchange
- IHRT Nasdaq
- RAPT Nasdaq
- Market Cap
- IHRT 454.9M
- RAPT 498.4M
- IPO Year
- IHRT 2019
- RAPT 2019
- Fundamental
- Price
- IHRT $2.67
- RAPT $29.34
- Analyst Decision
- IHRT Buy
- RAPT Buy
- Analyst Count
- IHRT 3
- RAPT 8
- Target Price
- IHRT $2.92
- RAPT $35.13
- AVG Volume (30 Days)
- IHRT 606.8K
- RAPT 305.8K
- Earning Date
- IHRT 11-06-2025
- RAPT 11-11-2025
- Dividend Yield
- IHRT N/A
- RAPT N/A
- EPS Growth
- IHRT N/A
- RAPT N/A
- EPS
- IHRT N/A
- RAPT N/A
- Revenue
- IHRT $3,867,156,000.00
- RAPT N/A
- Revenue This Year
- IHRT $0.22
- RAPT N/A
- Revenue Next Year
- IHRT $6.06
- RAPT N/A
- P/E Ratio
- IHRT N/A
- RAPT N/A
- Revenue Growth
- IHRT 3.18
- RAPT N/A
- 52 Week Low
- IHRT $0.95
- RAPT $5.67
- 52 Week High
- IHRT $3.33
- RAPT $32.35
- Technical
- Relative Strength Index (RSI)
- IHRT 49.08
- RAPT 67.42
- Support Level
- IHRT $2.61
- RAPT $24.25
- Resistance Level
- IHRT $2.85
- RAPT $30.93
- Average True Range (ATR)
- IHRT 0.20
- RAPT 2.71
- MACD
- IHRT -0.05
- RAPT -0.48
- Stochastic Oscillator
- IHRT 26.85
- RAPT 61.11
About IHRT iHeartMedia Inc.
iHeartMedia Inc is a United States-based audio media company. The company operates through the segments of the Multiplatform Group, the Digital Audio Group, and the Audio & Media Services Group. The company derives prime revenue from the Multiplatform Group segment which includes the company's Broadcast radio, Networks and Sponsorships, and Events businesses. The Digital Audio Group segment includes all of the company's digital businesses, including podcasting; and the Audio & Media Services Group includes Katz Media Group, a full-service media representation business, and RCS Sound Software, a provider of scheduling and broadcast software and services.
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.